Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Vaso Occlusive Crisis (VOC)”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Study completedNCT02515838
What this trial is testing

Sevuparin Infusion for the Management of Acute VOC in Subjects With SCD

Who this might be right for
Sickle-Cell Disease
Modus Therapeutics AB 147
Not applicableStudy completedNCT03478917
What this trial is testing

Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging

Who this might be right for
Sickle Cell Disease (SCD)
National Heart, Lung, and Blood Institute (NHLBI) 65
Testing effectiveness (Phase 2)Ended earlyNCT04852172
What this trial is testing

L-citrulline Injection in Patients Aged 6-21 Years Old with Sickle Cell Disease Presenting with Vaso-Occlusive Crisis (VOC)

Who this might be right for
Acute Vaso Occlusive Crisis (VOC)
Asklepion Pharmaceuticals, LLC 30
Large-scale testing (Phase 3)Ended earlyNCT04927247
What this trial is testing

A Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises

Who this might be right for
Sickle Cell DiseaseVaso-occlusive CrisisVaso-occlusive Pain Episode in Sickle Cell Disease
Pfizer 72